Five years after Congress passed the landmark law, shortcomings persist, which are potentially hampering patients and physicians, House leaders contend. 

The Australia-based drug manufacturer is working to release Pixclara, a PET contrast agent for diagnosing glioma, a rare form of brain cancer. 

Reuters reported that 500 institutions are linked to the proposals. In total, $50 million is up for grabs as part of HHS’ Autism Data Science Initiative.

The new Liberty System allows users to remotely deliver and manipulate guidewires and catheters during peripheral endovascular procedures.

CMS has proposed a policy shift that would allow cardiac ablation procedures to be performed in ambulatory surgical centers. Arash Aryana, MD, PhD, a veteran cardiac electrophysiologist, explained why he is "extremely encouraged" by this proposal, highlighting several potential benefits. 

The U.S. Department of Health and Human Services is set to release a report this month outlining possible causes of autism spectrum disorder. The Wall Street Journal reports that it names “low folate levels and acetaminophen during pregnancy” as contributing factors.

AI could appreciably improve the delivery of healthcare services to patients—if only people trusted it. For many, the difference-maker would be nicely crafted federal regulations. 

More than 100,000 surgical devices are included in these recalls, and there may be "limited product availability" in the months ahead. The FDA first warned the public about this issue in August.